Skip to main content
Top
Published in: American Journal of Clinical Dermatology 5/2008

01-10-2008 | Current Opinion

Can We Define Acne as a Chronic Disease?

If So,How and When?

Authors: Dr Harald P.M. Gollnick, Andrew Y. Finlay, Neil Shear, on behalf of the Global Alliance to Improve Outcomes in Acne

Published in: American Journal of Clinical Dermatology | Issue 5/2008

Login to get access

Abstract

There is widespread misunderstanding of acne amongst both the medical and lay community, who often perceive the condition to be a simple, self-limited affliction of adolescents. Because many think that the disease “will go away on its own,” they do not feel an urgency to aggressively treat acne. However, very often the reality is that acne treatment can be quite difficult. Furthermore, acne can be a devastating disease for the patient, since it manifests on visible body parts and in children near puberty, who are vulnerable both socially and psychologically. Most typically, acne is not an acute disease but rather a condition that continuously changes in its distribution and severity. Usually, acne treatment is necessary for many months and sometimes years. Despite treatment, acne may cause scarring and associated negative psychological effects. It is important for both patients and physicians to be aware that very effective treatments are available. It is also important to realize that new studies have proven the benefit of maintenance therapy with topical retinoids; these agents can minimize the potential for relapse, which is part of the natural history of acne. This article reviews the evidence suggesting that acne is a chronic disease in at least a subset of individuals. The members of the Global Alliance to Improve Outcomes in Acne believe that acne should be recognized and investigated as a chronic disease. This will change expectations of clinical trial design and treatment and will highlight gaps in the knowledge of acne epidemiology. The result should be an improvement in patient outcomes.
Literature
2.
go back to reference O’Halloran J, Miller GC, Britt H.Defining chronic conditions for primary care with ICPC-2. Fam Pract 2004; 21: 381–6PubMedCrossRef O’Halloran J, Miller GC, Britt H.Defining chronic conditions for primary care with ICPC-2. Fam Pract 2004; 21: 381–6PubMedCrossRef
3.
go back to reference Bornman J. The World Health Organisation’s terminology and classification:application to severe disability. Disabil Rehab 2004; 26: 182–8CrossRef Bornman J. The World Health Organisation’s terminology and classification:application to severe disability. Disabil Rehab 2004; 26: 182–8CrossRef
4.
go back to reference Cunliffe WJ. Acne. London: Martin Dunitz Ltd, 1989: 2–4 Cunliffe WJ. Acne. London: Martin Dunitz Ltd, 1989: 2–4
5.
go back to reference Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Invest Derm 2004; 9: 126–30CrossRef Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Invest Derm 2004; 9: 126–30CrossRef
6.
go back to reference Neimeir V, Kupfer J, Demmelbauer-Ebner M,eaet al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 196: 108–15CrossRef Neimeir V, Kupfer J, Demmelbauer-Ebner M,eaet al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 196: 108–15CrossRef
7.
go back to reference Gollnick H, Cunliffe W, Berson D,et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1–37PubMedCrossRef Gollnick H, Cunliffe W, Berson D,et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1–37PubMedCrossRef
8.
go back to reference Thiboutot DM, Shalita AR, Yamauchi PS, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597–602PubMedCrossRef Thiboutot DM, Shalita AR, Yamauchi PS, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597–602PubMedCrossRef
9.
go back to reference Leyden J, Thiboutot DM, Shalita AR, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006; 142: 605–12PubMedCrossRef Leyden J, Thiboutot DM, Shalita AR, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006; 142: 605–12PubMedCrossRef
10.
go back to reference Zhang ZJ, Li LF, Tu YT, et al. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372–8PubMedCrossRef Zhang ZJ, Li LF, Tu YT, et al. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372–8PubMedCrossRef
11.
go back to reference Alirezai M, George SA, Coutts I,et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol 2007; 17: 45–51PubMed Alirezai M, George SA, Coutts I,et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol 2007; 17: 45–51PubMed
12.
go back to reference Zane LT. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638–40PubMedCrossRef Zane LT. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638–40PubMedCrossRef
13.
go back to reference Thiboutot DM, Lookingbill DP. Acne: acute or chronic disease? J Am Acad Dermatol 1995; 32: 2–5CrossRef Thiboutot DM, Lookingbill DP. Acne: acute or chronic disease? J Am Acad Dermatol 1995; 32: 2–5CrossRef
15.
go back to reference Chew EW, Bingham A, Burrow D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 376–7PubMedCrossRef Chew EW, Bingham A, Burrow D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 376–7PubMedCrossRef
17.
go back to reference Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46: S98–106PubMedCrossRef Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46: S98–106PubMedCrossRef
18.
go back to reference Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and adults. BMJ 1979; 166: 1109–10CrossRef Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and adults. BMJ 1979; 166: 1109–10CrossRef
19.
go back to reference Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297–300PubMedCrossRef Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297–300PubMedCrossRef
20.
go back to reference Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541–5PubMedCrossRef Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541–5PubMedCrossRef
21.
go back to reference Tan JKL. The Canadian Acne Epidemiological Survey: baseline demographics and interim analysis. J Am Acad Dermatol 2004; 50 Suppl. 2: P15CrossRef Tan JKL. The Canadian Acne Epidemiological Survey: baseline demographics and interim analysis. J Am Acad Dermatol 2004; 50 Suppl. 2: P15CrossRef
23.
go back to reference Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273–82PubMedCrossRef Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273–82PubMedCrossRef
25.
go back to reference Krowschuk DP, Stancin T, Keskinen R, et al. The psychoscial effects of acne on adolescents. Pediatr Dermatol 1991; 8 (4): 332–8CrossRef Krowschuk DP, Stancin T, Keskinen R, et al. The psychoscial effects of acne on adolescents. Pediatr Dermatol 1991; 8 (4): 332–8CrossRef
26.
go back to reference Kilkenny M, Merlin K, Plunkett A, et al. The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris. Br J Dermatol 1998; 139: 840–5PubMedCrossRef Kilkenny M, Merlin K, Plunkett A, et al. The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris. Br J Dermatol 1998; 139: 840–5PubMedCrossRef
27.
go back to reference Kilkenny M, Stathakis V, Hibbert ME,et al. Acne in Victorian adolescents: associations with age, gender, puberty and psychiatric symptoms. J Paediatr Child Health 1997; 33: 430–3PubMedCrossRef Kilkenny M, Stathakis V, Hibbert ME,et al. Acne in Victorian adolescents: associations with age, gender, puberty and psychiatric symptoms. J Paediatr Child Health 1997; 33: 430–3PubMedCrossRef
28.
go back to reference Baldwin HE. The interaction between acne vulgaris and the psyche. Cutis 2002; 70: 133–9PubMed Baldwin HE. The interaction between acne vulgaris and the psyche. Cutis 2002; 70: 133–9PubMed
29.
go back to reference Kligman AM. Postadolescent acne in women. Cutis 1992; 48: 218–22 Kligman AM. Postadolescent acne in women. Cutis 1992; 48: 218–22
30.
go back to reference Smith RN, Mann NJ, Braue A,et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247–56PubMedCrossRef Smith RN, Mann NJ, Braue A,et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247–56PubMedCrossRef
31.
go back to reference Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007; 57: 819–23PubMedCrossRef Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007; 57: 819–23PubMedCrossRef
32.
go back to reference Treloar V, Logan AC, Danby FW,et al. Comment on acne and glycemic index. J Am Acad Dermatol 2008; 58: 175–7PubMedCrossRef Treloar V, Logan AC, Danby FW,et al. Comment on acne and glycemic index. J Am Acad Dermatol 2008; 58: 175–7PubMedCrossRef
33.
go back to reference Schafer T, Nienhaus A, Vieluf D,et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100–4PubMedCrossRef Schafer T, Nienhaus A, Vieluf D,et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100–4PubMedCrossRef
34.
go back to reference Till AE, Gouden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000; 142: 885–92PubMedCrossRef Till AE, Gouden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000; 142: 885–92PubMedCrossRef
35.
36.
go back to reference Cunliffe WJ, Gollnick HPM. Acne: diagnosis and management. London: Taylor & Francis,2001 Cunliffe WJ, Gollnick HPM. Acne: diagnosis and management. London: Taylor & Francis,2001
37.
go back to reference Giannetti A, Girolomoni G. Atopic dermatitis. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 69–71 Giannetti A, Girolomoni G. Atopic dermatitis. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 69–71
38.
go back to reference Burgdorf W. Acne vulgaris. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 74–6 Burgdorf W. Acne vulgaris. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 74–6
39.
go back to reference Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672–6PubMedCrossRef Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672–6PubMedCrossRef
40.
go back to reference Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39: 354–7PubMedCrossRef Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39: 354–7PubMedCrossRef
41.
go back to reference Lasek RJ, Chren M-M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454–8PubMedCrossRef Lasek RJ, Chren M-M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454–8PubMedCrossRef
42.
go back to reference Thielitz A, Helmdach M, R¨opke E-M, et al. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.Br J Dermatol 2001; 145: 19–27PubMedCrossRef Thielitz A, Helmdach M, R¨opke E-M, et al. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.Br J Dermatol 2001; 145: 19–27PubMedCrossRef
43.
go back to reference Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 741–53CrossRef Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 741–53CrossRef
44.
go back to reference Cunliffe WJ, Holland DB, Clark SM,et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084–91PubMedCrossRef Cunliffe WJ, Holland DB, Clark SM,et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084–91PubMedCrossRef
Metadata
Title
Can We Define Acne as a Chronic Disease?
If So,How and When?
Authors
Dr Harald P.M. Gollnick
Andrew Y. Finlay
Neil Shear
on behalf of the Global Alliance to Improve Outcomes in Acne
Publication date
01-10-2008
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2008
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200809050-00001

Other articles of this Issue 5/2008

American Journal of Clinical Dermatology 5/2008 Go to the issue